CXCL10 and neoplasm: To test whether the genetic deletion of Cxcl10 has an impact on the tumor-associated immune response during fibrosis-associated hepatocarcinogenesis, we evaluated potential differences in the immune cell repertoire in the liver tissues of the WT and Cxcl10−/− mice via multiparametric flow cytometry and immunohistological staining.